**Core Concept**
Oral contraceptive pills (OCPs) are a hormone-based medication that contain estrogen and progesterone or progesterone alone. They work by altering the hormonal balance in the body, which in turn affects various physiological processes. In the context of gynecology, OCPs are primarily used to prevent pregnancy and also have several non-contraceptive benefits.

**Why the Correct Answer is Right**
Hepatic adenoma is a rare, benign tumor of the liver that is associated with the use of OCPs. The exact mechanism by which OCPs increase the risk of hepatic adenoma is unclear, but it is thought to be related to the effects of estrogen on liver cell growth. In contrast, OCPs have been shown to decrease the risk of ovarian cancer, salpingitis (inflammation of the fallopian tubes), and fibroadenosis (a condition characterized by the growth of non-cancerous lumps in the breast).

**Why Each Wrong Option is Incorrect**
**Option A:** Salpingitis is a condition that can be caused by a variety of factors, including bacterial infections and sexually transmitted diseases. OCPs have been shown to decrease the risk of salpingitis by reducing the number of menstrual cycles, which in turn reduces the exposure of the fallopian tubes to potential pathogens.
**Option C:** Ovarian cancer is a type of cancer that affects the ovaries. OCPs have been shown to decrease the risk of ovarian cancer, likely due to the effects of estrogen and progesterone on ovarian cell growth and differentiation.
**Option D:** Fibroadenosis is a condition characterized by the growth of non-cancerous lumps in the breast. OCPs have been shown to decrease the risk of fibroadenosis, likely due to the effects of estrogen and progesterone on breast tissue.

**Clinical Pearl / High-Yield Fact**
It's essential to note that while OCPs have several non-contraceptive benefits, they can also have potential risks, such as an increased risk of blood clots and stroke. Therefore, OCPs should be prescribed with caution, and patients should be carefully evaluated for any underlying medical conditions that may increase their risk of adverse effects.

**✓ Correct Answer: B. Hepatic adenoma**